Outsourcing Outlook

Dec 07, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
M&A activity, new business models, fundraising limits, offerings from small CDMOs, and combination products are driving decisions in the contract services market.
Dec 02, 2016
Pharmaceutical Technology
Biosimilars may be the key to CMO growth.
Nov 02, 2016
Pharmaceutical Technology
CMO executives are focusing on M&A activity, new business models, and fundraising limits.
Oct 02, 2016
Pharmaceutical Technology
This key bioprocessing segment is expecting continued growth.
Sep 02, 2016
Pharmaceutical Technology
The strategies of a innovation-driven CMO may be different than a capacity-driven CMO.
Aug 02, 2016
Pharmaceutical Technology
CMOs are working hard to improve performance by investigating new technologies for filtration and purification.
Jul 06, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
Bio/pharma companies that are qualifying potential contract service providers should investigate post-merger integration activities and capital structure as part of the due diligence.
Jul 02, 2016
Pharmaceutical Technology
CDMOs need to be aware that unfavorable public markets put emerging bio/pharma R&D spending at risk in 2017.
Jun 02, 2016
Pharmaceutical Technology
Acquisition binges often lead to hangovers; here’s what to watch out for.
May 02, 2016
Pharmaceutical Technology
Growth may be slowing, but outsourcing activity remains healthy.
native1_300x100
lorem ipsum